Literature DB >> 27436899

Saturation scanning of ubiquitin variants reveals a common hot spot for binding to USP2 and USP21.

Isabel Leung1, Ayelet Dekel2, Julia M Shifman3, Sachdev S Sidhu4.   

Abstract

A detailed understanding of the molecular mechanisms whereby ubiquitin (Ub) recognizes enzymes in the Ub proteasome system is crucial for understanding the biological function of Ub. Many structures of Ub complexes have been solved and, in most cases, reveal a large structural epitope on a common face of the Ub molecule. However, owing to the generally weak nature of these interactions, it has been difficult to map in detail the functional contributions of individual Ub side chains to affinity and specificity. Here we took advantage of Ub variants (Ubvs) that bind tightly to particular Ub-specific proteases (USPs) and used phage display and saturation scanning mutagenesis to comprehensively map functional epitopes within the structural epitopes. We found that Ubvs that bind to USP2 or USP21 contain a remarkably similar core functional epitope, or "hot spot," consisting mainly of positions that are conserved as the wild type sequence, but also some positions that prefer mutant sequences. The Ubv core functional epitope contacts residues that are conserved in the human USP family, and thus it is likely important for the interactions of Ub across many family members.

Entities:  

Keywords:  USP; hot spots; phage display; saturation scanning; ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27436899      PMCID: PMC4978272          DOI: 10.1073/pnas.1524648113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Combinatorial alanine-scanning.

Authors:  K L Morrison; G A Weiss
Journal:  Curr Opin Chem Biol       Date:  2001-06       Impact factor: 8.822

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 3.  Hematopoietic receptor complexes.

Authors:  J A Wells; A M de Vos
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

4.  Mapping of the binding landscape for a picomolar protein-protein complex through computation and experiment.

Authors:  Yonatan Aizner; Oz Sharabi; Jason Shirian; George R Dakwar; Marina Risman; Orly Avraham; Julia Shifman
Journal:  Structure       Date:  2014-03-06       Impact factor: 5.006

Review 5.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

6.  UbSRD: The Ubiquitin Structural Relational Database.

Authors:  Joseph S Harrison; Tim M Jacobs; Kevin Houlihan; Koenraad Van Doorslaer; Brian Kuhlman
Journal:  J Mol Biol       Date:  2015-09-25       Impact factor: 5.469

Review 7.  Ubiquitin-binding domains.

Authors:  James H Hurley; Sangho Lee; Gali Prag
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

8.  Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain.

Authors:  J Spence; R R Gali; G Dittmar; F Sherman; M Karin; D Finley
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

9.  Analyses of the effects of all ubiquitin point mutants on yeast growth rate.

Authors:  Benjamin P Roscoe; Kelly M Thayer; Konstantin B Zeldovich; David Fushman; Daniel N A Bolon
Journal:  J Mol Biol       Date:  2013-01-30       Impact factor: 5.469

10.  A strategy for modulation of enzymes in the ubiquitin system.

Authors:  Andreas Ernst; George Avvakumov; Jiefei Tong; Yihui Fan; Yanling Zhao; Philipp Alberts; Avinash Persaud; John R Walker; Ana-Mirela Neculai; Dante Neculai; Andrew Vorobyov; Pankaj Garg; Linda Beatty; Pak-Kei Chan; Yu-Chi Juang; Marie-Claude Landry; Christina Yeh; Elton Zeqiraj; Konstantina Karamboulas; Abdellah Allali-Hassani; Masoud Vedadi; Mike Tyers; Jason Moffat; Frank Sicheri; Laurence Pelletier; Daniel Durocher; Brian Raught; Daniela Rotin; Jianhua Yang; Michael F Moran; Sirano Dhe-Paganon; Sachdev S Sidhu
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

View more
  20 in total

1.  Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.

Authors:  Gang Chen; Jonathan D Cook; Wei Ye; Jeffrey E Lee; Sachdev S Sidhu
Journal:  Protein Sci       Date:  2019-08       Impact factor: 6.725

2.  Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.

Authors:  Svenja Wiechmann; Anne Gärtner; Andreas Kniss; Andreas Stengl; Christian Behrends; Vladimir V Rogov; Manuel S Rodriguez; Volker Dötsch; Stefan Müller; Andreas Ernst
Journal:  J Biol Chem       Date:  2017-08-07       Impact factor: 5.157

3.  Linkage-Specific Synthesis of Di-ubiquitin Probes Enabled by the Incorporation of Unnatural Amino Acid ThzK.

Authors:  Han Zhou; Tomaya Carpenter; Xuan Fu; Bo Jin; Britton Ody; Mohammad Sazid Hassan; Savannah E Jacobs; Jenny Cheung; Eve M Nicholson; Mark Turlington; Bo Zhao; Sonja Lorenz; T Ashton Cropp; Jun Yin
Journal:  Chembiochem       Date:  2022-03-19       Impact factor: 3.461

4.  Identification of an autoinhibitory, mitophagy-inducing peptide derived from the transmembrane domain of USP30.

Authors:  Xuan Qin; Rui Wang; Hongkun Xu; Licheng Tu; Hailing Chen; Heng Li; Na Liu; Jinpeng Wang; Shuiming Li; Feng Yin; Naihan Xu; Zigang Li
Journal:  Autophagy       Date:  2022-01-06       Impact factor: 13.391

5.  Quantitative mapping of binding specificity landscapes for homologous targets by using a high-throughput method.

Authors:  Lidan Aharon; Shay-Lee Aharoni; Evette S Radisky; Niv Papo
Journal:  Biochem J       Date:  2020-05-15       Impact factor: 3.857

6.  Massively parallel phenotyping of coding variants in cancer with Perturb-seq.

Authors:  Oana Ursu; James T Neal; Emily Shea; Pratiksha I Thakore; Livnat Jerby-Arnon; Lan Nguyen; Danielle Dionne; Celeste Diaz; Julia Bauman; Mariam Mounir Mosaad; Christian Fagre; April Lo; Maria McSharry; Andrew O Giacomelli; Seav Huong Ly; Orit Rozenblatt-Rosen; William C Hahn; Andrew J Aguirre; Alice H Berger; Aviv Regev; Jesse S Boehm
Journal:  Nat Biotechnol       Date:  2022-01-20       Impact factor: 68.164

7.  Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.

Authors:  Wei Zhang; Ben A Bailey-Elkin; Robert C M Knaap; Baldeep Khare; Tim J Dalebout; Garrett G Johnson; Puck B van Kasteren; Nigel J McLeish; Jun Gu; Wenguang He; Marjolein Kikkert; Brian L Mark; Sachdev S Sidhu
Journal:  PLoS Pathog       Date:  2017-05-18       Impact factor: 6.823

Review 8.  Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants.

Authors:  Maryna Gorelik; Sachdev S Sidhu
Journal:  Bioeng Transl Med       Date:  2016-11-14

9.  Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces.

Authors:  Shira Warszawski; Aliza Borenstein Katz; Rosalie Lipsh; Lev Khmelnitsky; Gili Ben Nissan; Gabriel Javitt; Orly Dym; Tamar Unger; Orli Knop; Shira Albeck; Ron Diskin; Deborah Fass; Michal Sharon; Sarel J Fleishman
Journal:  PLoS Comput Biol       Date:  2019-08-23       Impact factor: 4.475

10.  Design of a basigin-mimicking inhibitor targeting the malaria invasion protein RH5.

Authors:  Shira Warszawski; Elya Dekel; Ivan Campeotto; Jennifer M Marshall; Katherine E Wright; Oliver Lyth; Orli Knop; Neta Regev-Rudzki; Matthew K Higgins; Simon J Draper; Jake Baum; Sarel J Fleishman
Journal:  Proteins       Date:  2019-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.